Reimbursement, Redistribution of COVID-19 Therapeutics and More
The January 5, 2022 COVID-19 Therapeutics Brief includes detailed information on the following highlights.
- Using Therapeutics to Prevent and Treat COVID-19
- Therapeutic Resources
- Redistribution Requests for Therapeutics
- Informational Letter from Iowa Department of Human Services, Iowa Medicaid Enterprise Regarding Monoclonal Antibody Reimbursement
- Weekly Allocations Cadence for Monoclonal Antibodies, Pre-Exposure Prophylaxis Treatment and Antivirals
Healthcare provider questions regarding COVID-19 therapeutics can be directed to the C19 Therapeutics Call Center at (515) 281-7317 or emailed to C19Therapeutics@idph.iowa.gov.